Pykus Therapeutics
Friedrich Asmus, MD, serves as Chief Development Officer (Consultant) at Pykus Therapeutics and Chief Executive Officer at Ocular Clinical Consulting GmbH, providing expertise in translational and clinical stage development for ophthalmology and related fields since January 2025. As a Private Lecturer of Neurology at University Hospital of Tübingen since May 2011, Friedrich focuses on General Neurology and Neurodegenerative Diseases. Prior roles include Chief Medical Officer at Oxular, Senior Vice President of Clinical Development and Medical Affairs at jCyte, Vice President of Clinical Development at ProQR Therapeutics, and Global Clinical Leader in Ophthalmology at Bayer Pharmaceuticals. A strong background in neurology is complemented by experience at the Hospital of the University of Tübingen, with significant involvement in clinical trials and research on neurodegenerative diseases and related therapies. Educational qualifications include a Doctor of Medicine (MD) from Ludwig-Maximilians-University, Munich.
This person is not in any teams
This person is not in any offices
Pykus Therapeutics
Pykus Therapeutics, Inc. was founded in 2016 to develop a dissolvable intraocular surgical device to make retinal surgery less painful and more successful.The co-founders were ophthalmology residents at the Massachusetts Eye and Ear Infirmary and Harvard Medical School when they developed a novel hydrogel to replace the use of intraocular gasduring retinal surgery. This innovation will eliminate the extreme burden placed on patients including the requirement for face-down positioning, inability to see for weeks, and inability to fly for weeks.